PMED — Piu Medical Share Price
- €40.30m
- €37.89m
- €6.62m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.1 | ||
| Price to Tang. Book | 3.97 | ||
| Price to Free Cashflow | 21.87 | ||
| Price to Sales | 2.97 | ||
| EV to EBITDA | 55.8 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.41% | ||
| Return on Equity | -0.04% | ||
| Operating Margin | 1.51% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | 25.03 | 26.07 | 6.62 | n/a | n/a | -48.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +5.79 | -94.16 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Piu Medical S.p.A. is an Italy-based company that operates in the retail pharmacy, healthcare services, and wellness industry. The Company manages a network of pharmacies in Italy, providing pharmaceutical products, over-the-counter medicines, supplements and personal care products, wellness solutions, and pharmacy-based healthcare services. Its offer includes prescription dispensing, health consultations, diagnostic and screening services, customer loyalty programs, as well as digital customer support channels. The Company combines pharmacy retail operations with healthcare service delivery, serving consumers through physical pharmacy locations and service booking platforms. It serves its clients domestically.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- January 1st, 1970
- Public Since
- November 20th, 2025
- No. of Employees
- 82
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
Borsa Italiana
- Shares in Issue
- 7,533,333

- Address
- Viale Lombardia 62, Castronno, 21040
- Web
- http://www.piumedical.com
- Phone
- +39 800200001
- Auditors
- BDO Italia S.p.A.
Latest News for PMED
Similar to PMED
FAQ
As of Today at 04:44 UTC, shares in Piu Medical are trading at €5.35. This share price information is delayed by 15 minutes.
Shares in Piu Medical last closed at €5.35 and the price had moved by over the past 365 days. In terms of relative price strength the Piu Medical share price has matched the FTSE Global All Cap Index by over the past year.
There is no consensus recommendation for this security.
Find out morePiu Medical does not currently pay a dividend.
Piu Medical does not currently pay a dividend.
Piu Medical does not currently pay a dividend.
To buy shares in Piu Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €5.35, shares in Piu Medical had a market capitalisation of €40.30m.
Here are the trading details for Piu Medical:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: PMED
Based on an overall assessment of its quality, value and momentum Piu Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Piu Medical. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -8.92%.
As of the last closing price of €5.35, shares in Piu Medical were trading -8.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Piu Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €5.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Piu Medical's directors





